These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7818838)

  • 1. Prognostic significance of microalbuminuria.
    Viberti G
    Am J Hypertens; 1994 Sep; 7(9 Pt 2):69S-72S. PubMed ID: 7818838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria in non-insulin-dependent diabetes.
    Mogensen CE; Damsgaard EM; Frøland A; Nielsen S; de Fine Olivarius N; Schmitz A
    Clin Nephrol; 1992; 38 Suppl 1():S28-39. PubMed ID: 1295705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
    Viberti G; Chaturvedi N
    Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and prognostic significance of albuminuria in diabetes.
    Viberti G
    Diabetes Care; 1988; 11(10):840-5. PubMed ID: 3073075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH; Perkins BA; Silva KH; Finkelstein DM; Ignatowska-Switalska H; Gaciong Z; Cupples LA; Aschengrau A; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2007 May; 2(3):461-9. PubMed ID: 17699452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria: an important diagnostic tool.
    Feldt-Rasmussen B; Borch-Johnsen K; Deckert T; Jensen G; Jensen JS
    J Diabetes Complications; 1994; 8(3):137-45. PubMed ID: 8086648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria, blood pressure, metabolic control, and renal involvement: longitudinal studies in white non-insulin-dependent diabetic patients.
    Schmitz A
    Am J Hypertens; 1997 Sep; 10(9 Pt 2):189S-197S. PubMed ID: 9324121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in understanding mechanisms and natural history of diabetic renal disease.
    Viberti G
    Diabetes Care; 1988; 11 Suppl 1():3-9. PubMed ID: 3069389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of renal and cardiovascular mortality in patients with non-insulin-dependent diabetes: a brief overview of microalbuminuria and insulin resistance.
    Mangrum A; Bakris GL
    J Diabetes Complications; 1997; 11(6):352-7. PubMed ID: 9365878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microalbuminuria in insulin-dependent diabetics: the prevention of diabetic nephropathy].
    Durruty P; Krause P; Pérez F; García de los Ríos M; López G; Durruty G
    Rev Med Chil; 1990 Dec; 118(12):1319-25. PubMed ID: 2152662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.